Insights

Innovative Genomic Platforms WaferGen Biosystems offers cutting-edge single-cell analysis and biomarker validation platforms such as the ICELL8 Single-Cell System and SmartChip platform, providing solutions for advanced genomic research and clinical diagnostics.

Strong Industry Focus The company's technology is tailored for biotechnology research, pharmaceutical development, and clinical laboratories, presenting opportunities to collaborate with organizations seeking precise molecular and single-cell analysis tools.

Recent Acquisition As a wholly-owned subsidiary of Takara Bio USA, Inc., WaferGen benefits from increased backing and market reach, making it an attractive prospect for partners interested in integrating innovative genomic systems within larger biotech portfolios.

Growing Revenue Potential With estimated revenue between 10 and 25 million dollars and recent product launches, there is significant growth potential for sales of genomic automation systems and consumables to research institutes, biotech firms, and healthcare providers.

Complementary Technologies WaferGen's solutions align well with industry leaders like Illumina and Thermo Fisher Scientific, creating opportunities for strategic partnerships, distribution channels, or technology integrations to expand market penetration.

WaferGen Biosystems Tech Stack

WaferGen Biosystems uses 6 technology products and services including Google Fonts API, yepnope.js, jQuery, and more. Explore WaferGen Biosystems's tech stack below.

  • Google Fonts API
    Font Scripts
  • yepnope.js
    Javascript Frameworks
  • jQuery
    Javascript Libraries
  • Modernizr
    Javascript Libraries
  • Bootstrap
    UI Frameworks
  • Google Analytics
    Web Analytics

WaferGen Biosystems's Email Address Formats

WaferGen Biosystems uses at least 1 format(s):
WaferGen Biosystems Email FormatsExamplePercentage
First.Last@wafergen.comJohn.Doe@wafergen.com
85%
FLast@wafergen.comJDoe@wafergen.com
8%
First@wafergen.comJohn@wafergen.com
5%
First.Middle@wafergen.comJohn.Michael@wafergen.com
2%

Frequently Asked Questions

Where is WaferGen Biosystems's headquarters located?

Minus sign iconPlus sign icon
WaferGen Biosystems's main headquarters is located at 34700 Campus Drive Fremont, California 94555 United States. The company has employees across 3 continents, including North AmericaEuropeAsia.

What is WaferGen Biosystems's phone number?

Minus sign iconPlus sign icon
You can contact WaferGen Biosystems's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is WaferGen Biosystems's official website and social media links?

Minus sign iconPlus sign icon
WaferGen Biosystems's official website is wafergen.com and has social profiles on LinkedInCrunchbase.

What is WaferGen Biosystems's SIC code NAICS code?

Minus sign iconPlus sign icon
WaferGen Biosystems's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does WaferGen Biosystems have currently?

Minus sign iconPlus sign icon
As of April 2026, WaferGen Biosystems has approximately 21 employees across 3 continents, including North AmericaEuropeAsia. Key team members include Vp Engineering: C. Z.Director Of Sales: M. D.Operations Manager: A. L. M.. Explore WaferGen Biosystems's employee directory with LeadIQ.

What industry does WaferGen Biosystems belong to?

Minus sign iconPlus sign icon
WaferGen Biosystems operates in the Biotechnology Research industry.

What technology does WaferGen Biosystems use?

Minus sign iconPlus sign icon
WaferGen Biosystems's tech stack includes Google Fonts APIyepnope.jsjQueryModernizrBootstrapGoogle Analytics.

What is WaferGen Biosystems's email format?

Minus sign iconPlus sign icon
WaferGen Biosystems's email format typically follows the pattern of First.Last@wafergen.com. Find more WaferGen Biosystems email formats with LeadIQ.

How much funding has WaferGen Biosystems raised to date?

Minus sign iconPlus sign icon
As of April 2026, WaferGen Biosystems has raised $15M in funding. The last funding round occurred on Aug 27, 2013 for $15M.

WaferGen Biosystems

Biotechnology ResearchCalifornia, United States11-50 Employees

NOW PART OF TAKARA BIO USA, INC. -- Please visit the Takara Bio USA, Inc. company page for the latest updates: https://www.linkedin.com/company-beta/17509/ 

WaferGen automation systems include innovative genomic technology solutions for single-cell analysis and clinical research. 

The ICELL8® Single-Cell System is a revolutionary platform which can isolate thousands of single cells and enables selection and processing of specific cells for various analysis methods, including next generation sequencing. The system has demonstrated unbiased isolation of up to 1,800 single cells 5–100 µm in size on a single chip, including cells from solid tumors and brain tissues, pulmonary airway cells, and multiple cell lines. 

The SmartChip™ platform can be used for profiling and validating molecular biomarkers, and can perform massively parallel singleplex PCR for one-step NGS library preparation in clinical applications. 

The Apollo™ 324 system can be used to process DNA and RNA obtained from clinical samples into NGS-ready libraries. 

These technologies offer a powerful set of tools for biological analysis at the molecular and single-cell levels in the life sciences, pharmaceutical, and clinical laboratory industries.

Section iconCompany Overview

Headquarters
34700 Campus Drive Fremont, California 94555 United States
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
11-50

Section iconFunding & Financials

  • $15M

    WaferGen Biosystems has raised a total of $15M of funding over 5 rounds. Their latest funding round was raised on Aug 27, 2013 in the amount of $15M.

  • $10M$25M

    WaferGen Biosystems's revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $15M

    WaferGen Biosystems has raised a total of $15M of funding over 5 rounds. Their latest funding round was raised on Aug 27, 2013 in the amount of $15M.

  • $10M$25M

    WaferGen Biosystems's revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.